buflomedil and cilostazol

buflomedil has been researched along with cilostazol in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Landi, A	1
Dobesh, PP; Persson, EL; Stacy, ZA	1

Reviews

2 review(s) available for buflomedil and cilostazol

Article	Year
[Secondary prevention and conservative therapy of obliterative arteriosclerosis]. Orvosi hetilap, 2004, May-16, Volume: 145, Issue:20 Topics: Arteriosclerosis Obliterans; Cilostazol; Clinical Trials as Topic; Epoprostenol; Exercise; Hematologic Agents; Hemodilution; Hemorheology; Humans; Hyperhomocysteinemia; Hypolipidemic Agents; Intermittent Claudication; Nafronyl; Pentoxifylline; Platelet Aggregation Inhibitors; Pyrrolidines; Risk Factors; Smoking; Tetrazoles; Vasodilator Agents; Walking	2004
Pharmacologic therapy for intermittent claudication. Pharmacotherapy, 2009, Volume: 29, Issue:5 Topics: Cilostazol; Clinical Trials as Topic; Dietary Supplements; Drugs, Investigational; Exercise Therapy; Guidelines as Topic; Humans; Intermittent Claudication; Meta-Analysis as Topic; Nafronyl; Pentoxifylline; Peripheral Vascular Diseases; Pyrrolidines; Risk Factors; Tetrazoles; Treatment Outcome	2009

Article

Year

[Secondary prevention and conservative therapy of obliterative arteriosclerosis].

Orvosi hetilap, 2004, May-16, Volume: 145, Issue:20

Topics: Arteriosclerosis Obliterans; Cilostazol; Clinical Trials as Topic; Epoprostenol; Exercise; Hematologic Agents; Hemodilution; Hemorheology; Humans; Hyperhomocysteinemia; Hypolipidemic Agents; Intermittent Claudication; Nafronyl; Pentoxifylline; Platelet Aggregation Inhibitors; Pyrrolidines; Risk Factors; Smoking; Tetrazoles; Vasodilator Agents; Walking

2004

Pharmacologic therapy for intermittent claudication.

Pharmacotherapy, 2009, Volume: 29, Issue:5

Topics: Cilostazol; Clinical Trials as Topic; Dietary Supplements; Drugs, Investigational; Exercise Therapy; Guidelines as Topic; Humans; Intermittent Claudication; Meta-Analysis as Topic; Nafronyl; Pentoxifylline; Peripheral Vascular Diseases; Pyrrolidines; Risk Factors; Tetrazoles; Treatment Outcome

2009